Logo image of BLDR

BUILDERS FIRSTSOURCE INC (BLDR) Stock Fundamental Analysis

USA - NYSE:BLDR - US12008R1077 - Common Stock

122.54 USD
-0.41 (-0.33%)
Last: 10/17/2025, 8:04:01 PM
122.75 USD
+0.21 (+0.17%)
After Hours: 10/17/2025, 8:04:01 PM
Fundamental Rating

4

Taking everything into account, BLDR scores 4 out of 10 in our fundamental rating. BLDR was compared to 41 industry peers in the Building Products industry. While BLDR is still in line with the averages on profitability rating, there are concerns on its financial health. BLDR is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

BLDR had positive earnings in the past year.
BLDR had a positive operating cash flow in the past year.
BLDR had positive earnings in each of the past 5 years.
Each year in the past 5 years BLDR had a positive operating cash flow.
BLDR Yearly Net Income VS EBIT VS OCF VS FCFBLDR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of 6.60%, BLDR is in line with its industry, outperforming 53.66% of the companies in the same industry.
The Return On Equity of BLDR (18.10%) is better than 68.29% of its industry peers.
With a Return On Invested Capital value of 9.90%, BLDR perfoms like the industry average, outperforming 56.10% of the companies in the same industry.
BLDR had an Average Return On Invested Capital over the past 3 years of 22.36%. This is significantly above the industry average of 12.70%.
The last Return On Invested Capital (9.90%) for BLDR is well below the 3 year average (22.36%), which needs to be investigated, but indicates that BLDR had better years and this may not be a problem.
Industry RankSector Rank
ROA 6.6%
ROE 18.1%
ROIC 9.9%
ROA(3y)16.93%
ROA(5y)14.89%
ROE(3y)37.68%
ROE(5y)35.24%
ROIC(3y)22.36%
ROIC(5y)20.5%
BLDR Yearly ROA, ROE, ROICBLDR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

BLDR has a worse Profit Margin (4.74%) than 63.41% of its industry peers.
BLDR's Profit Margin has improved in the last couple of years.
The Operating Margin of BLDR (7.70%) is worse than 63.41% of its industry peers.
In the last couple of years the Operating Margin of BLDR has grown nicely.
BLDR's Gross Margin of 31.58% is in line compared to the rest of the industry. BLDR outperforms 48.78% of its industry peers.
BLDR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.7%
PM (TTM) 4.74%
GM 31.58%
OM growth 3Y-6.99%
OM growth 5Y12.55%
PM growth 3Y-8.82%
PM growth 5Y16.6%
GM growth 3Y3.73%
GM growth 5Y3.86%
BLDR Yearly Profit, Operating, Gross MarginsBLDR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

3

2. Health

2.1 Basic Checks

BLDR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, BLDR has less shares outstanding
Compared to 5 years ago, BLDR has less shares outstanding
Compared to 1 year ago, BLDR has a worse debt to assets ratio.
BLDR Yearly Shares OutstandingBLDR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BLDR Yearly Total Debt VS Total AssetsBLDR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

The Debt to FCF ratio of BLDR is 3.93, which is a good value as it means it would take BLDR, 3.93 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 3.93, BLDR perfoms like the industry average, outperforming 53.66% of the companies in the same industry.
A Debt/Equity ratio of 1.12 is on the high side and indicates that BLDR has dependencies on debt financing.
BLDR's Debt to Equity ratio of 1.12 is on the low side compared to the rest of the industry. BLDR is outperformed by 82.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF 3.93
Altman-Z N/A
ROIC/WACC1.08
WACC9.15%
BLDR Yearly LT Debt VS Equity VS FCFBLDR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.79 indicates that BLDR should not have too much problems paying its short term obligations.
The Current ratio of BLDR (1.79) is comparable to the rest of the industry.
BLDR has a Quick Ratio of 1.08. This is a normal value and indicates that BLDR is financially healthy and should not expect problems in meeting its short term obligations.
BLDR has a Quick ratio of 1.08. This is in the lower half of the industry: BLDR underperforms 60.98% of its industry peers.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.08
BLDR Yearly Current Assets VS Current LiabilitesBLDR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

3

3. Growth

3.1 Past

BLDR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.50%.
BLDR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 40.71% yearly.
Looking at the last year, BLDR shows a decrease in Revenue. The Revenue has decreased by -6.39% in the last year.
Measured over the past years, BLDR shows a quite strong growth in Revenue. The Revenue has been growing by 17.64% on average per year.
EPS 1Y (TTM)-33.5%
EPS 3Y4.76%
EPS 5Y40.71%
EPS Q2Q%-32%
Revenue 1Y (TTM)-6.39%
Revenue growth 3Y-6.23%
Revenue growth 5Y17.64%
Sales Q2Q%-4.99%

3.2 Future

The Earnings Per Share is expected to decrease by -7.26% on average over the next years.
The Revenue is expected to grow by 0.03% on average over the next years.
EPS Next Y-39.57%
EPS Next 2Y-20%
EPS Next 3Y-7.26%
EPS Next 5YN/A
Revenue Next Year-7.11%
Revenue Next 2Y-2.6%
Revenue Next 3Y0.03%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLDR Yearly Revenue VS EstimatesBLDR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B
BLDR Yearly EPS VS EstimatesBLDR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.22 indicates a correct valuation of BLDR.
BLDR's Price/Earnings ratio is rather cheap when compared to the industry. BLDR is cheaper than 85.37% of the companies in the same industry.
BLDR is valuated cheaply when we compare the Price/Earnings ratio to 27.40, which is the current average of the S&P500 Index.
BLDR is valuated correctly with a Price/Forward Earnings ratio of 16.61.
The rest of the industry has a similar Price/Forward Earnings ratio as BLDR.
BLDR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.22
Fwd PE 16.61
BLDR Price Earnings VS Forward Price EarningsBLDR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BLDR is valued a bit cheaper than 73.17% of the companies in the same industry.
90.24% of the companies in the same industry are more expensive than BLDR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.4
EV/EBITDA 10.11
BLDR Per share dataBLDR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

The decent profitability rating of BLDR may justify a higher PE ratio.
A cheap valuation may be justified as BLDR's earnings are expected to decrease with -7.26% in the coming years.
PEG (NY)N/A
PEG (5Y)0.32
EPS Next 2Y-20%
EPS Next 3Y-7.26%

More info and screens

0

5. Dividend

5.1 Amount

BLDR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BUILDERS FIRSTSOURCE INC

NYSE:BLDR (10/17/2025, 8:04:01 PM)

After market: 122.75 +0.21 (+0.17%)

122.54

-0.41 (-0.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners100.23%
Inst Owner Change-0.17%
Ins Owners2.49%
Ins Owner Change4.27%
Market Cap13.55B
Analysts75.56
Price Target142.66 (16.42%)
Short Float %7.45%
Short Ratio3.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.42%
Min EPS beat(2)2.38%
Max EPS beat(2)12.47%
EPS beat(4)4
Avg EPS beat(4)6.07%
Min EPS beat(4)1.07%
Max EPS beat(4)12.47%
EPS beat(8)8
Avg EPS beat(8)12.44%
EPS beat(12)12
Avg EPS beat(12)27.52%
EPS beat(16)16
Avg EPS beat(16)42.11%
Revenue beat(2)0
Avg Revenue beat(2)-2.44%
Min Revenue beat(2)-2.96%
Max Revenue beat(2)-1.92%
Revenue beat(4)0
Avg Revenue beat(4)-7.3%
Min Revenue beat(4)-17.56%
Max Revenue beat(4)-1.92%
Revenue beat(8)1
Avg Revenue beat(8)-4.98%
Revenue beat(12)5
Avg Revenue beat(12)-1.63%
Revenue beat(16)9
Avg Revenue beat(16)2.64%
PT rev (1m)0%
PT rev (3m)-1.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-31.9%
EPS NY rev (1m)-1%
EPS NY rev (3m)-15.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.42%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-6.19%
Valuation
Industry RankSector Rank
PE 13.22
Fwd PE 16.61
P/S 0.85
P/FCF 11.4
P/OCF 8.59
P/B 3.24
P/tB N/A
EV/EBITDA 10.11
EPS(TTM)9.27
EY7.56%
EPS(NY)7.38
Fwd EY6.02%
FCF(TTM)10.75
FCFY8.78%
OCF(TTM)14.26
OCFY11.64%
SpS144.23
BVpS37.79
TBVpS-9.71
PEG (NY)N/A
PEG (5Y)0.32
Profitability
Industry RankSector Rank
ROA 6.6%
ROE 18.1%
ROCE 12.75%
ROIC 9.9%
ROICexc 9.99%
ROICexgc 22.22%
OM 7.7%
PM (TTM) 4.74%
GM 31.58%
FCFM 7.46%
ROA(3y)16.93%
ROA(5y)14.89%
ROE(3y)37.68%
ROE(5y)35.24%
ROIC(3y)22.36%
ROIC(5y)20.5%
ROICexc(3y)22.6%
ROICexc(5y)21.09%
ROICexgc(3y)52.47%
ROICexgc(5y)46.44%
ROCE(3y)28.8%
ROCE(5y)26.39%
ROICexcg growth 3Y-14.33%
ROICexcg growth 5Y9.79%
ROICexc growth 3Y-13.16%
ROICexc growth 5Y2.57%
OM growth 3Y-6.99%
OM growth 5Y12.55%
PM growth 3Y-8.82%
PM growth 5Y16.6%
GM growth 3Y3.73%
GM growth 5Y3.86%
F-Score4
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF 3.93
Debt/EBITDA 2.6
Cap/Depr 67.97%
Cap/Sales 2.43%
Interest Coverage 5.27
Cash Conversion 87.67%
Profit Quality 157.18%
Current Ratio 1.79
Quick Ratio 1.08
Altman-Z N/A
F-Score4
WACC9.15%
ROIC/WACC1.08
Cap/Depr(3y)73.83%
Cap/Depr(5y)71.85%
Cap/Sales(3y)2.2%
Cap/Sales(5y)1.81%
Profit Quality(3y)125.27%
Profit Quality(5y)102.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-33.5%
EPS 3Y4.76%
EPS 5Y40.71%
EPS Q2Q%-32%
EPS Next Y-39.57%
EPS Next 2Y-20%
EPS Next 3Y-7.26%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.39%
Revenue growth 3Y-6.23%
Revenue growth 5Y17.64%
Sales Q2Q%-4.99%
Revenue Next Year-7.11%
Revenue Next 2Y-2.6%
Revenue Next 3Y0.03%
Revenue Next 5YN/A
EBIT growth 1Y-38.45%
EBIT growth 3Y-12.79%
EBIT growth 5Y32.41%
EBIT Next Year0.24%
EBIT Next 3Y5.03%
EBIT Next 5YN/A
FCF growth 1Y-61.23%
FCF growth 3Y-0.52%
FCF growth 5Y30.71%
OCF growth 1Y-55.18%
OCF growth 3Y2.41%
OCF growth 5Y30.02%